Congress Materials

Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Marjolein de Bruin-Weller, Stephan Weidinger, Melinda Gooderham, Andrew Pink, Jonathan Silverberg, Marco DiBonaventura, Urs Kerkmann, Irina Lazariciu, Claire Clibborn December 15, 2021 RAD December 2021 Atopic Dermatitis

Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals

View Presentation
Oral Presentation
Marjolein de Bruin-Weller, Stephan Weidinger, Melinda Gooderham, Andrew Pink, Jonathan Silverberg, Marco DiBonaventura, Urs Kerkmann, Irina Lazariciu, Claire Clibborn December 15, 2021 RAD December 2021 Atopic Dermatitis

Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals

View Presentation
Poster
Jonathan I. Silverberg, Andrew Blauvelt, Eric L. Simpson, Jacob P. Thyssen, Pinaki Biswas, Claire Feeney, Ricardo Rojo, Herwig Koppensteiner, Erman Guler, Urs Kerkmann, Stephan Weidinger December 15, 2021 RAD December 2021 Atopic Dermatitis

Identifying Patient Subgroups With Comparable Benefit From Continuous Versus Reduced Abrocitinib Maintenance Doses in JADE REGIMEN

View Presentation
Oral Presentation
Jonathan I. Silverberg, Andrew Blauvelt, Eric L. Simpson, Jacob P. Thyssen, Pinaki Biswas, Claire Feeney, Ricardo Rojo, Herwig Koppensteiner, Erman Guler, Urs Kerkmann, Stephan Weidinger December 15, 2021 RAD December 2021 Atopic Dermatitis

Identifying Patient Subgroups With Comparable Benefit From Continuous Versus Reduced Abrocitinib Maintenance Doses in JADE REGIMEN

View Presentation
Poster
Jacob P. Thyssen, H. Chih-ho Hong, Marjolein de Bruin-Weller, Roland Aschoff, April W. Armstrong, Raj Chovatiya, Christian Vestergaard, Ricardo Rojo, Hernan Valdez, Fan Zhang, Ankur Bhambri, Daniela E. Myers, Kimberly Watson, Erman Guler, Claire Clibborn, Marco DiBonaventura December 15, 2021 RAD December 2021 Atopic Dermatitis

Improvement in Patient-Reported Symptoms and Quality of Life With Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Who Received Background Topical Therapy: Results of a 26-Week, Randomized, Head-to-Head Trial

View Presentation
Poster
Michael Ardern-Jones, Mahreen Ameen, Marjolein de Bruin-Weller, Eric Simpson, Wing Sin Chiu, Pinaki Biswas, Gary Chan, Christopher Koulias, Stephan Weidinger December 15, 2021 RAD December 2021 Atopic Dermatitis

Long-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Who Had Failed or Were Intolerant to Oral Non-Steroidal Immunosuppressants: Pooled Analysis of JADE Clinical Trials

View Presentation
Oral Presentation
Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong, Kilian Eyerich, Zakiya Pressley Rice, Ankur Bhambri, Erman Guler, Fan Zhang, Ricardo Rojo, Gary Chan, Claire Clibborn December 15, 2021 RAD December 2021 Atopic Dermatitis

Onset and Depth of Response with Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Phase 3b JADE DARE Clinical Trial

View Presentation
Poster
Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong, Kilian Eyerich, Zakiya Pressley Rice, Ankur Bhambri, Erman Guler, Fan Zhang, Ricardo Rojo, Gary Chan, Claire Clibborn December 15, 2021 RAD December 2021 Atopic Dermatitis

Onset and Depth of Response with Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Phase 3b JADE DARE Clinical Trial

View Presentation
Poster
Jashin J. Wu, H. Chih-ho Hong, Joseph F. Merola, David Gruben, Erman Guler, Claire Feeney, Ankur Bhambri, Daniela E. Myers, Marco DiBonaventura December 15, 2021 RAD December 2021 Atopic Dermatitis

Predictors of Nonresponse to Dupilumab in Patients With Atopic Dermatitis: A Machine Learning Analysis of United States Health Records and Claims Data

View Presentation
Poster
Eric L. Simpson, Kristian Reich, Jonathan I. Silverberg, Adnan Nasir, Paulo Ricardo Criado, Pinaki Biswas, Herwig Koppensteiner, Dorothy Fan, Ricardo Rojo, Saleem A. Farooqui December 15, 2021 RAD December 2021 Atopic Dermatitis

Protocol for an Ongoing, Phase 3 Multicenter, Long-Term Extension Study Investigating the Long-Term Safety and Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis (JADE EXTEND)

View Presentation